Jian Zhao

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster et al. · Blood · 2020 · 322 citations · Full text

Medicine, Hematology, Oncology +13

A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma

Xiang Xiao, Ya Wen Liu, Ling Zhang et al. · Anti-Cancer Drugs · 2012 · 108 citations

Pharmacy, Oncology, Pharmacotherapy +16

Multi-parametric MRI in cervical cancer: early prediction of response to concurrent chemoradiotherapy in combination with clinical prognostic factors

Wei Yang, Jinwei Qiang, Hai Ping Tian et al. · European Radiology · 2017 · 40 citations

Medicine, Oncology, Radiology +14

A Phase II Study of Capecitabine plus Oxaliplatin as First-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer

Xiao Xiang, Ling Zhang, Feng Qiu et al. · Chemotherapy · 2012 · 32 citations

Pharmacy, Oncology, Pharmacology +17

XELOX doublet regimen versus EOX triplet regimen as first‐line treatment for advanced gastric cancer: An open‐labeled, multicenter, randomized, prospective phase III trial (EXELOX)

Xiao‐Dong Zhu, Mingzhu Huang, Yusheng Wang et al. · Cancer Communications · 2022 · 32 citations · Full text

Medicine, Oncology, Pharmacotherapy +10